bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic

Go back to bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic
(NASDAQ: BIAF) Delayed: 3.57 -0.09 (2.46%)
Previous Close $3.66    52 Week High $ 
Open $3.68    52 Week Low $ 
Day High $3.69    P/E N/A 
Day Low $3.54    EPS $ 
Volume 55,458       

(NASDAQ: BIAFW) Delayed: 0.32 --0 (-0%)
Previous Close $0.32    52 Week High $ 
Open $0.32    52 Week Low $ 
Day High $0.32    P/E N/A 
Day Low $0.32    EPS $ 
Volume 905,781